.png) | |
 | |
| Names | |
|---|---|
| Preferred IUPAC name 2-Amino-1-(3,4-dimethoxyphenyl)ethan-1-ol | |
| Other names 3,4-Dimethoxy-beta-hydroxyphenethylamine 3,4-Dimethoxy-1-ethyl-(beta-hydroxy)amine | |
| Identifiers | |
3D model (JSmol) | |
| ChemSpider |
|
| UNII | |
| |
| |
| Properties | |
| C10H15NO3 | |
| Molar mass | 197.234 g·mol−1 |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |
DME, also known as3,4-dimethoxy-β-hydroxyphenethylamine, is a lesser-knownpsychoactive drug of theBOx family. It is the β-hydroxyderivative of3,4-dimethoxyphenethylamine. DME was first synthesized byAlexander Shulgin. In his bookPiHKAL, the minimum dosage is listed as 115 mg, and the duration unknown. DME produces few to no effects.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of DME.
This substance is a Class A drug in theDrugs controlled by the UK Misuse of Drugs Act.[2]
 | Thispsychoactive drug-related article is astub. You can help Wikipedia byexpanding it. |
